Strategies for nonviral nanoparticle‐based delivery of CRISPR/Cas9 therapeutics

Chen, Fengqian, Alphonse, Martin, Liu, Qi·2020·WIREs Nanomedicine and Nanobiotechnology
DOI 10.1002/wnan.1609

Cited by (197)

Items 101–197 of 197

  1. Genome-editing approaches and applications: a brief review on CRISPR technology and its role in cancer
    Narmadhaa Siva, Sonal Gupta, Ayam Gupta, Jayendra Nath Shukla, Babita Malik, Nidhi Shukla · 2021 · 3 Biotech
  2. Tailoring Magnetite-Nanoparticle-Based Nanocarriers for Gene Delivery: Exploiting CRISPRa Potential in Reducing Conditions
    David Arango, Javier Cifuentes, Paola Ruiz Puentes, Tatiana Beltran, Amaury Bittar, Camila Ocasión, Carolina Muñoz-Camargo, Natasha I. Bloch, Luis H. Reyes, Juan C. Cruz · 2023 · Nanomaterials
  3. RETRACTED ARTICLE: Revolutionizing Lung Cancer Treatment: Innovative CRISPR-Cas9 Delivery Strategies
    Dilpreet Singh · 2024 · AAPS PharmSciTech · Retracted
  4. Genetical engineering for NK and T cell immunotherapy with CRISPR/Cas9 technology: Implications and challenges
    Lingtong Zhi, Xin Su, Meichen Yin, Zikang Zhang, Hui Lü, Zhiyuan Niu, Changjiang Guo, Wuling Zhu, Xuan Zhang · 2021 · Cellular Immunology
  5. Recent advancements on use of CRISPR /Cas9 in maize yield and quality improvement
    Syed Faheem Anjum Gillani, Adnan Rasheed, Yasir Majeed, Huma TARIQ, Peng YUNLING · 2021 · Notulae Botanicae Horti Agrobotanici Cluj-Napoca
  6. Elevated expression of exogenous RAD51 enhances the CRISPR/Cas9-mediated genome editing efficiency
    Seo Jung Park, Seobin Yoon, Eui-Hwan Choi, Hana Hyeon, Kangseok Lee, Keun Pil Kim · 2023 · BMB Reports
  7. Nanomaterials in gene therapy and genome editing: challenges and emerging directions
    Mingyang Jiang, Ke Zhang, Zheng Wang, Ming Gao, Shanggui Su, Junjun He, Huihui Xu, Zhandong Bo, Zhenqi Jiang, Chengcheng Zhang et al. · 2025 · Journal of Nanobiotechnology
  8. Directed mutagenesis in plants through genome editing using guide RNA library
    Suman Dutta, Debashis Paul, Anjan Das, Sudhir Kumar, Amitava Roy, Anindita Barua, Viswanathan Chinnusamy · 2024 · The Nucleus
  9. Robust aptamer-targeted CRISPR/Cas9 delivery using mesenchymal stem cell membrane –liposome hybrid: BIRC5 gene knockout against melanoma
    Asma Ghaemi, Khalil Abnous, Seyed Mohammad Taghdisi, Masoumeh Vakili-Azghandi, Mohammad Ramezani, Mona Alibolandi · 2024 · Nanomedicine Nanotechnology Biology and Medicine
  10. Delivery of functional Cas:DNA nucleoprotein complexes into recipient bacteria through a type IV secretion system
    Dolores L. Guzmán-Herrador, Andrea Fernández-Gómez, Florence Depardieu, David Bikard, Matxalen Llosa · 2024 · Proceedings of the National Academy of Sciences
  11. CRISPR/Cas‐SERS Sensing Platforms: A Frontier Technology for Next‐Generation Fast, Low‐Cost, Ultra‐Micro Biosample Detection
    Chengxin Bao, Xiangguo Liu, Chongyang Liang, Shuping Xu · 2025 · Journal of Raman Spectroscopy
  12. Nanoparticle-mediated delivery of non-viral gene editing technology to the brain
    Lucian Williams, Jessica Larsen · 2023 · Progress in Neurobiology
  13. Hyaluronidase-responsive polymeric nanomaterials for targeted antimicrobial therapy: Structure–function relationships and biomaterial design strategy
    Nazia Tabassum, Riza Jane S. Banicod, Aqib Javaid, Young Mog Kim, Fazlurrahman Khan · 2025 · International Journal of Biological Macromolecules
  14. Gene editing strategies to treat lysosomal disorders: The example of mucopolysaccharidoses
    Flávia Nathiely Silveira Fachel, Lariane Frâncio, Édina Poletto, Roselena Silvestri Schuh, Hélder Ferreira Teixeira, Roberto Giugliani, Guilherme Baldo, Úrsula da Silveira Matte · 2022 · Advanced Drug Delivery Reviews
  15. CRISPR-Cas9 in Pharmaceutical Research: Applications, Challenges, Ethical Considerations and Future Directions
    Mukund M. Pache, Rutuja R. Pangavhane, Siddhi V. Nikam, Ramdas B Rode, Avinash B. Darekar · 2025 · Research Journal of Science and Technology
  16. Recent advances in CRISPR-Cas systems for colorectal cancer research and therapeutics
    Saeideh Khorshid Sokhangouy, Farzaneh Lal Alizadeh, Malihe Lotfi, Samaneh Sharif, Atefeh Ashouri, Yasamin Yoosefi, Saeed Bozorg Qomi, Mohammad Reza Abbaszadegan · 2024 · Expert Review of Molecular Diagnostics
  17. Recombinant vaccines: Current updates and future prospects
    Vivek Kumar, Anuj Verma, Riddhi Singh, Priyanshi Garg, Santosh Kumar Sharma, Himanshu Narayan Singh, Santosh Kumar Mishra, Sanjay Kumar · 2024 · Asian Pacific Journal of Tropical Medicine
  18. Lipids and lipid derivatives for delivery of the CRISPR/Cas9 system
    Zaid Saad Madhi, Mohammed Ali Shallan, Abdulhusein Mizhir Almaamuri, Ammar Abbas Alhussainy, Sadiq Salam H. AL-Salih, Abdulla K. Raheem, Hameed Jassem Alwan, Abduladheem Turki Jalil · 2022 · Journal of Drug Delivery Science and Technology
  19. Intelligent micro-electro-mechanical system for predictive nano-drug synthesis: Acousto-microfluidic heat and mass transportation
    Afshin Kouhkord, Faridoddin Hassani, Ali Golshani, Reza Ansari · 2025 · Results in Engineering
  20. Base and Prime Editing for Inherited Retinal Diseases: Delivery Platforms, Safety, Efficacy, and Translational Perspectives
    Haoliang Zhang, Yuxuan Li, Jiajie Li, Xiaosa Li, Tong Li · 2025 · Pharmaceutics
  21. The role of bacteriophages and CRISPR-Cas in combating multidrug-resistant bacteria
    Ciamak Ghazaei · 2026 · Natural Products and Bioprospecting
  22. Targeted degradation of hexokinase 2 for anti‑inflammatory treatment in acute lung injury
    Jiayan Yang, Liangliang Dong, Yifan Wang, Lifen Gong, Hongwei Gao, Yicheng Xie · 2024 · Molecular Medicine Reports
  23. Therapeutic Applications of the CRISPR-Cas System
    Kyungmin Kang, Youngjae Song, Inho Kim, Tae Jung Kim · 2022 · Bioengineering
  24. Delivery of Therapeutic Biopolymers Employing Silica-Based Nanosystems
    Zoila Gándara, Noelia Rubio, Rafael R. Castillo · 2023 · Pharmaceutics
  25. Hairpin Internal Nuclear Localization Signals in CRISPR-Cas9 Enhance Editing in Primary Human Lymphocytes
    Eric A. Noel, Srishti U. Sahu, Stacia K. Wyman, Netravathi Krishnappa, Chris Jeans, Ross C. Wilson · 2025 · The CRISPR Journal
  26. CRISPR/Cas9 gene editing strategy for cancer therapy: non-viral nanocarrier-mediated delivery of plasmids, RNA and ribonucleoprotein complexes
    Zutong Cui, Wenming Liang, Jian Li, Zhimin Bai · 2025 · International Journal of Biological Macromolecules
  27. CRISPR/Cas9 genome editing-based preclinical theranostics, biomarkers and drug delivery systems for cancer applications
    Aseem Setia, Dipali Patil, Nandini Vinodrao Randhave, Vaishali, Nidhi Verma, Komal Rani, Akshay Kale, Bhima Wagh, Vikas Kumar, Ankit Kumar Malik et al. · 2026 · International Journal of Biological Macromolecules
  28. CRISPR/CAS as a Powerful Tool for Human Immunodeficiency Virus Cure: A Review
    Shirley Vasconcelos Komninakis, Wilson Domingues, Sabri Saeed Sanabani, Víctor Ângelo Folgosi, Igor Neves Barbosa, Jorge Casseb · 2024 · AIDS Research and Human Retroviruses
  29. Nanoparticle-based CRISPR/Cas Delivery: An Emerging Tactic for Cancer Therapy
    Fahima Dilnawaz, Sarbari Acharya · 2022 · Current Medicinal Chemistry
  30. Repurposing Prokaryotic Clustered Regularly Interspaced Short Palindromic Repeats-Cas Adaptive Immune System to Combat Antimicrobial Resistance
    Veena Devi, Kusum Harjai, Sanjay Chhibber · 2023 · Future Microbiology
  31. Engineering mesoporous silica nanoparticles for cancer immunotherapy: mechanistic insights, therapeutic synergies, and translational roadmap
    Adel Mahmoudi Gharehbaba, Fatemeh Soltanmohammadi, Morteza Eskandani, Khosro Adibkia · 2026 · Materials & Design
  32. Nanocarrier-mediated CRISPR-Cas delivery: a novel approach against antibiotic-resistant superbugs
    Fawaz M. Almufarriji · 2026 · Saudi Pharmaceutical Journal
  33. ADVANCEMENT OF CROP PRODUCTIVITY VIA CRISPR-NANOPARTICLE INTERFACE
    Amir Afzal, Sairah Syed, Mishal Khizar, Javed Iqbal, Sharmin Ashraf, Aneesa Altaf, Basharat Mehmood, Muhammad Rashid Khan · 2023 · Pakistan Journal of Biotechnology
  34. Clearance of residual genome editing components used for ex vivo genome-editing of allogeneic cell therapy products
    Alex Chialastri, Hunter Hoffman, Damien Fink, Jennifer L. Dashnau · 2024 · Cytotherapy
  35. Genetic frontiers: Exploring the latest strategies in gene delivery
    Sheikh Shahnawaz Quadir, Devendra Choudhary, Supriya Singh, Deepak K. Choudhary, Minhua Chen, Garima Joshi · 2024 · Journal of Drug Delivery Science and Technology
  36. An overview on in-vivo generation of CAR-T cells using CRISPR-loaded functionalized nanocarriers for treating B-cell lineage acute lymphoblastic leukemia
    Tushara Saha, Rudra P. Saha, Manoj Kumar Singh, Kanu Priya, Shareen Singh, Mithul Rajeev, Debasmita Bhattacharya, Moupriya Nag, Dibyajit Lahiri · 2025 · Molecular Biology Reports
  37. Nucleic acid strategies for infectious disease treatments: The nanoparticle-based oral delivery route
    Fengqian Chen, Qi Liu, Yang Xiong, Li Xu · 2022 · Frontiers in Pharmacology
  38. Metal Nanoparticles: Synthesis, Characterization, and Biomedical Applications
    Sivasankar Putta, Raj Kumar Sharma, Puneet Khandelwal · 2023 · Springer eBooks
  39. Dibenzocyclooctyne‐Branched Primer Assembled Gene Nanovector and Its Potential Applications in Genome Editing
    Liqing Lu, Dunkang Rao, Cuili Niu, Longhuai Cheng, Dejun Ma, Zhen Xi · 2022 · ChemBioChem
  40. Therapeutic Applications of Natural Products in Biomedicine and Pharmacotherapy
    Ashok Kumar Sah, Sakshi Patel, Dr.R .Pranesh Kumar, Prem Shankar Mishra, Rakhi Mishra, Абдулхаков Ихтиёр Умарович, Rabab H. Elshaikh, Shagun Agarwal, Ashwani Bhardwaj, Ranjay Kumar Choudhary et al. · 2026 · Life
  41. Mannosylated neutrophil vesicles targeting macrophages alleviate liver inflammation by delivering CRISPR/Cas9 RNPs
    Dongqing Wu, Hang Shu, Mengmeng Zhang, Xiaoli Wei, Jingjing Ji, Haiyuan Shen, Hejiao Zhang, Linxi Xie, Liangliang Zhou, Lei Fu Yang et al. · 2025 · Theranostics
  42. Medical nanoscale materials for virus-induced cervical cancer therapeutic modalities: For targeting delivery
    Adane Adugna, Mamaru Getinet, Gashaw Azanaw Amare, Mohammed Jemal · 2024 · OpenNano
  43. CRISPR/Cas Genome Editing in Engineering Plant Secondary Metabolites of Therapeutic Benefits
    Tuyelee Das, Mimosa Ghorai, Devendra Kumar Pandey, Radha, Mamta Thakur, Sonia Rathour, Abdel Rahman Al-Tawaha, Ercan Bursal, Vinay Kumar, Potshangbam Nongdam et al. · 2022 · Springer eBooks
  44. CRISPR/Cas9-3NLS/sgHMGA2@PDA nanosystem is the potential efficient gene editing therapy for gastric cancer with HMGA2 high expression
    Zhouying Wu, Xue Huo, Tingyu Yang, Kun Liu, Ting Wu, Zongqi Feng, Min Wang, Feng Li, Jianchao Jia, Xiaoran Zhang et al. · 2022 · Frontiers in Oncology
  45. Integrating CRISPR with SERS: Toward intelligent point-of-care diagnostics of the future
    Biqing Chen, Jiayin Gao, Haizhu Sun, Yinghan Zhao, Yan Liu, Xiaohong Qiu, Yang Li · 2025 · Clinica Chimica Acta
  46. CRISPR-driven strategies to disrupt methicillin-resistant Staphylococcus aureus biofilms: a review
    Jose Jurel M. Nuevo, Jamil Allen G. Fortaleza, Kevin Smith P. Cabuhat, Christian Joseph N. Ong, Anna C. Jalova, Ferdinand A Mortel, Grace D. Bacalzo · 2026 · Frontiers in Cellular and Infection Microbiology
  47. Re-balancing immunity with CRISPR-Cas9: Novel strategies for cancer and autoimmune disorders
    Xuanqi Ren, Ziyang Zhou, Lingkai Kong, Yibo Guo, Yan Liu, Jiazhen Li, Xiaosong Gu, Chunping Jiang, Junhua Wu · 2026 · Biotechnology Advances
  48. Innovative Nanotechnology in CRISPR-Based Crop Genome Editing
    Osama Alam, Shahid Ullah Khan, Shareef Gul, Hameed Gul, Ikram Ullah · 2024 · Nanotechnology in the life sciences
  49. Gene Editing: a Powerful Tool for Cancer Immunotherapy
    2022 · Biointerface Research in Applied Chemistry
  50. Challenges and Emerging Molecular Approaches in Combating Antimicrobial Resistance
    Gene Philip Levee Ynion, Christian Jay Paeste Rosal, Arvin Zulueta, Angelo Ordanel, Christopher Marlowe A. Caipang · 2024 · Journal of Bacteriology and Virology
  51. Nanomedicine enables efficient CRISPR-Cas9 genome editing for disease treatment
    Lifang Ma, Caihong Dong, Meihua Yu, Xinran Song, Yongchun Yu, Yu Chen · 2021 · 中国科学通报：英文版
  52. Harnessing the Potential of Stimuli‐Responsive Double‐Network DNA Hydrogels Toward Nanotheranostics
    Kishika Arora, Shikha Awasthi · 2025 · Advanced Therapeutics
  53. Harnessing Nanotechnology and Gene Editing for Cancer Therapy: A Synergistic Approach to Precision Medicine
    Anjana Goel, Istuti Saraswat, Sahaj Sharma, Rijul Joshi · 1970 · Current Gene Therapy
  54. CRISPR/Cas-mediated genome editing: playing a versatile role in mitigating the challenges of sustainable rice improvement
    Byomkesh Dash, Sudhansu Sekhar Bhuyan, Raj Kishore Sahoo, Nibedita Swain, Kishor Jeughale, Suman Sarkar, Ramlakhan Verma, Chidambaranathan Parameswaran, B. N. Devanna, Sanghamitra Samantaray · 2025 · 3 Biotech
  55. Targeting the hallmarks of ageing: Pharmacological challenges and breakthroughs in CRISPR delivery systems and future prospects
    Sakshi Rathore, Akash Gupta, Kamal Shah, Nagendra Singh Chauhan, Sanjay Gupta · 2026 · Ageing Research Reviews
  56. Lipid Nanoparticles Delivery of CRISPR/Cas9 Targeting PCSK9 and ANGTPL3 as New Therapeutic Gene Editing Modalities for Potential Long-Lasting Treatment Of Dyslipidemia
    Ramidha Syaharani, Fauziah Adhima, Sarah Nia Amru, Reny I’tishom · 2021 · International Journal of Research Publications
  57. Novel Nanotechnology-Based Vector Delivery in CRISPR System for Transgene-Free Editing
    Sumbul Saeed, Adeel Ahmed, Sabzoi Nizamuddin, Sundus Saeed Qureshi, Raheel Shahzad, Nasr Ullah Khan, Muhammad Shaban, Muhammad Hafeez Ullah Khan, Shahid Ullah Khan · 2022 · Springer eBooks
  58. CRISPR/Cas9 Nano-delivery Approaches for Targeted Gene Therapy
    Eden Mariam Jacob, Ankita Borah, D. Sakthi Kumar · 2022 · Nanotechnology in the life sciences
  59. Modulating the tumor immune microenvironment with locoregional image-guided interventions
    Samagra Jain, Rahul A. Sheth · 2023 · Frontiers in Immunology
  60. The changing landscape of gene editing tool delivery in neurological disorders
    Y Chen, Abhik Paul, Michael G. Collins, Hye Young Lee · 2023 · Current Opinion in Biomedical Engineering
  61. Gene editing of angiotensin for blood pressure management
    Stefano Masi, Hermann Dalpiaz, Claudio Borghi · 2024 · International Journal of Cardiology Cardiovascular Risk and Prevention
  62. Nanotechnology-based approaches against COVID-19
    Samira Sadat Abolmaali, Vahid Alimardani, Ghazal Farahavar, Haniyeh Najafi, Mina Shafiee, Nader Tanideh, Ali Mohammad Tamaddon, Samad Ahadian · 2022 · Elsevier eBooks
  63. Advanced drug delivery systems for enhancing the efficacy of RNA-based therapeutics
    Nasser Ali Alhabib, Mohammed Abdulaziz Almaniea, Soliman Mohammed Alehaidib, Mohammed Ahmed Almansour, Mubarak Saad Aldosary, Maysam Taysir Almegbel, Sultan Abdullah Alsubaie, Ahlam Mohammed Alzahrani · 2022 · International Journal of Health Sciences
  64. Unraveling Etiological Indications and Therapeutic Implications of Familial Cerebral Cavernous Malformations in the Dawn of Gene Therapy for Monogenic Conditions
    Ke Ma, Moksada Regmi, Shikun Liu, Ying Xiong, Yingjie Wang, Weihai Liu, Yuwei Dai, Guozhong Lin, Jun Yang, Chenlong Yang · 2025 · Current Gene Therapy
  65. Harnessing Nanotechnology for Enhanced CRISPR-Cas Plant Genome Editing
    Harshali Shende, Rajendra Patil · 2025 · Springer eBooks
  66. Review: engineering CRISPR nanoparticle hybrid platforms for biofilm-associated antimicrobial resistance: delivery barriers, resistance reprogramming, and translational challenges
    Ahmed Mahdy, Omneya M. ElBakry, Omar Eladl, Alaa E. Etman, Youssef Atef Mohamed Attia, Asmaa K. Abdallah, Mohamed Ahmed Abdelmalek, Mariam W. Helal, Mona Hamdy, Gharieb Saied El-Sayyad et al. · 2026 · Nanotechnology
  67. CRISPR CAS-9 Mediated Genome Editing and One Health Related Diseases
    2023 · International Journal of Agriculture and Biosciences
  68. Current trends and risks associated with the use of therapies based on genome editing
    Рачинская Ольга Анатольевна, E. V. Melnikova, Вадим Анатольевич Меркулов · 2023 · Biological Products Prevention Diagnosis Treatment
  69. CRISPR-Cas-Mediated Optimization of Plant-Derived Natural Products of Biomedical Significance
    Arora Asha, J Varjani Sunita · 2024 · Reference series in phytochemistry
  70. The Plethora of RNA–Protein Interactions Model a Basis for RNA Therapies
    Stephen J. Dansereau, Hua Lei Cui, Ricky Dartawan, Jia Sheng · 2025 · Genes
  71. CRISPR/Cas9-Mediated Knockdown Of BRCA1/2 Restores Response To Olaparib In Pancreatic Cancer Cell Lines
    Andréa Witz, Julie Dardare, Aurélie François, Marie Husson, Marie Rouyer, Jessica Demange, Pauline Gilson, Jean‐Louis Merlin, Alexandre Harlé · 2022 · Research Square
  72. Nanotechnological tools for the diagnosis and treatment of cancer
    Fernanda Gonçalves Barbosa, Daylin Rubio Ribeaux, Carlos Augusto Ferreira Ramos Raymundo, David López Martinez, Emilio M. Serrano-López, Jesús Baltanás Copado, Paulo Ricardo Franco Marcelino · 2023 · Elsevier eBooks
  73. Comparison of Non-viral Delivery Vehicles for CRISPR/Cas9 Therapies
    Deborah Henry · 2023 · STEM Fellowship Journal
  74. Comparative Analysis of Lipid Nanoparticle-Mediated Delivery of CRISPR-Cas9 RNP Versus mRNA/sgRNA for Gene Editing in vitro and in vivo
    Johanna Walther, Deja Porenta, Danny Wilbie, Cornelis W. Seinen, Naomi Benne, Qiangbing Yang, Olivier G. de Jong, Zhiyong Lei, Enrico Mastrobattista · 2023 · SSRN Electronic Journal
  75. Lipid Nanoparticle-Mediated Delivery of CRISPR-Cas9 for Therapeutic Gene Correction
    Johanna Walther · 2023
  76. CRISPR workflow solutions: Cargos and versatile delivery platforms in genome editing
    Ahmad Munir, Muhammad Amjad Ali, Sameer Hasan Qari, Nayla Munawar, Muhammad Sulyman Saleem, Aftab Ahmad · 2024 · Elsevier eBooks
  77. Insights in RNA: 2022
    2024 · Frontiers research topics
  78. Strategies to target and genetically modify the liver sinusoid
    Lara J. Westwood, David George Le Couteur, Nicholas J. Hunt, Victoria Carroll Cogger · 2024 · Elsevier eBooks
  79. Neuroengineering: History, modeling, and deliverables
    Katherine L. Lucot, Renee E. Napoliello, Paula A Vij, Kyle D. Fink · 2024 · Elsevier eBooks
  80. CRISPR-Cas-Mediated Optimization of Plant-Derived Natural Products of Biomedical Significance
    Arora Asha, J Varjani Sunita · 2025 · Reference series in phytochemistry
  81. Innovation and Implication of CRISPR-Mediated T-cell Engineering in Cancer Immunotherapy: A New Insight
    Syeda Areej Imran, Hafiz Muhammad Sultan, Muhammad Zubair, Shakira Ghazanfar, Anas Islam, Syed Mustafizur Rahaman, Sumel Ashique · 2025 · Current Cancer Therapy Reviews
  82. Dual delivery of supramolecular nanoparticle-carried minicircle donor DNA with Cas9/gRNA improved HITI knock-in efficiency in X-linked juvenile retinoschisis
    Shih‐Jie Chou, Chia-Hao Wang, Yuh‐Lih Chang, Wei-Chieh Fang, De‐Kuang Hwang, Yu‐Jer Hsiao, Yung‐Hung Luo, Wen‐Liang Lo, Nguyen Quoc Viet, Kea-Yin Tang et al. · 2025 · International Journal of Biological Macromolecules
  83. Role of Biomaterials in Enhancing CRISPR Delivery Efficiency and Safety
    Mohit Pandey, Mayur Porwal, Phool Chandra, Vaibhav Rastogi, Krishana Kumar Sharma · 2025 · Macromolecular Symposia
  84. Biopharmaceutical Production from Cell Engineering and Molecular Pharming
    Anita Mishra, Ayushi Malik, Avinash Marwal, Rajarshi Kumar Gaur · 2026 · Springer eBooks
  85. CRISPR-Cas9 Technology for Epigenome Editing in Precision Medicine
    M M Nidhilangelo, Ranjith Kumavath · 2026 · IGI Global eBooks
  86. Future Directions in Nano-Virology
    Shumaila Ijaz, Naila Ijaz, Navid Hussain Shah, Javed Iqbal, Banzeer Ahsan Abbasi, Rahmat Ali, Syeda Anber Zahra, Ayush Madan, Ghulam Murtaza · 2026 · IGI Global eBooks
  87. Metallic Nanoparticles in Plant Genetic Engineering
    Sanam Ashraf, Javed Iqbal, Zubaria Tul Ain, Banzeer Ahsan Abbasi, Muhammad Anas, Tariq Mahmood, Sana Basharat, Muhammad Waseem · 2026 · Smart nanomaterials technology
  88. Opportunities and Obstacles for Using Nanotechnology to Modify Plant Genome
    Sana Khalid, Zainab Waheed, Samra Javaid, Sumera Iqbal · 2026 · Smart nanomaterials technology
  89. Investigating the potential of CRISPR-Cas9 gene editing technology for gene therapy in cancer
    Shahid Nazir Wani, Sukhbir Singh, Neelam Sharma, Tapan Behl, Ishrat Zahoor, Junaid Tantray · 2026 · Elsevier eBooks
  90. A Cryoprotectant‐Compatible Nanoporous Platform for Stable and Scalable Delivery of Biopharmaceuticals
    Sian Lee, Seongchan Kim, Jooyeun Chong, Min‐Gyeong Kim, Kayeong Lim, Nan‐Ee Lee, Jahyun Koo, Jiheong Kang, Hyojin Lee · 2026 · Advanced Materials
  91. Nanotechnologie(s), propriété intellectuelle et droits de l'homme
    Banu Kav Goseberg · 2022
  92. Emerging nanobiosensors and CRISPR-Cas9 nanocarriers: perspectives toward sustainable cancer diagnosis and therapy
    Rashmi Trivedi, ADESH KOLAPKAR, Anmol Gupta, Fareha Rayeen, Pratibha Pandey, Ajay Singh, Meenakshi Verma, Fahad Khan, Daniel Ejim Uti · 2026 · Green Chemistry Letters and Reviews
  93. Omics-Nano-CRISPR Strategies for Combating Prostate Cancer in the AI Age
    Ashok Kumar Sah, Dr.R .Pranesh Kumar, Sakshi Patel, Prem Shankar Mishra, Aryan Kumar, Shriram Sisodiya, Rabab H. Elshaikh · 2026 · IGI Global eBooks
  94. Nanoparticle-Mediated Gene Editing and Immunotherapy in Liver and Prostate Cancers
    S. Mayilazhagan, S. Dayana, T. Elavarasi, M. Manigandan, Krishnaswamy Veena Gayathri · 2026 · IGI Global eBooks
  95. Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases
    Zhuolin Fan, Xu Zheng, Chuan Jin, Jing Zhang, Ningqiang Gong, Xuexin Li · 2026 · Signal Transduction and Targeted Therapy
  96. Saponin conjugation improves p-CRISPR delivery by polyethylenimine modified carbon dots
    Ali Hamad Abd Kelkawi, Seyede Mahtab Kamrani Mousavi, Akbar Hasanzadeh, Sara Saeedi, Behjat Kheiri Yeghaneh Azar, Babak Kamali, Seyyed Emad Hooshmand, Mohadese Rastgoo Korande, Michael Richard Hamblin, Jawdat N. Gaaib et al. · 2026 · Bioimpacts
  97. Nano Delivery Systems for In Vivo CRISPR/Cas-Based Gene Therapy: From Vectors to Clinical Outcomes
    Ruhan Chen, Haimei Zhou, Qinjie Wu, Changyang Gong · 2026 · ACS Nano